Download the data set of PD-1 immunotherapy for clear cell renal cell carcinoma (ccRCC), and the results of Kaplan-Meier survival analysis indicated that the high expression of EFHD2 was significantly correlated with poor prognosis. The gene discussed is EFHD2; the disease is nonpapillary renal cell carcinoma.